Charles Schwab
ELGX

Charles Schwab’s Endologix Inc ELGX Stock Holding History

Charles Schwab’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-71,343
Closed -$517K – 3248
2019
Q2 		$517K Buy
71,343
+8,936
+14% +$61K ﹤0.01% 2796
2019
Q1 		$413K Buy
62,407
+8,816
+16% +$58.1K ﹤0.01% 2831
2018
Q4 		$384K Buy
53,591
+11,717
+28% +$130K ﹤0.01% 2855
2018
Q3 		$800K Sell
41,874
-1,123
-3% -$40.1K ﹤0.01% 2693
2018
Q2 		$2.43M Buy
42,997
+4,932
+13% +$250K ﹤0.01% 2314
2018
Q1 		$1.61M Buy
38,065
+3,059
+9% +$131K ﹤0.01% 2395
2017
Q4 		$1.87M Buy
35,006
+1,282
+4% +$67.7K ﹤0.01% 2333
2017
Q3 		$1.5M Buy
33,724
+1,593
+5% +$72.6K ﹤0.01% 2385
2017
Q2 		$1.56M Buy
32,131
+3,043
+10% +$179K ﹤0.01% 2305
2017
Q1 		$2.11M Buy
29,088
+1,556
+6% +$103K ﹤0.01% 2182
2016
Q4 		$1.57M Sell
27,532
-205
-0.7% -$18.8K ﹤0.01% 2273
2016
Q3 		$3.55M Buy
27,737
+1,285
+5% +$164K ﹤0.01% 1855
2016
Q2 		$3.3M Buy
26,452
+1,658
+7% +$191K ﹤0.01% 1818
2016
Q1 		$2.07M Buy
24,794
+3,668
+17% +$302K ﹤0.01% 2030
2015
Q4 		$2.09M Buy
21,126
+606
+3% +$65K ﹤0.01% 2053
2015
Q3 		$2.52M Buy
20,520
+422
+2% +$57.3K ﹤0.01% 1934
2015
Q2 		$3.08M Buy
20,098
+1,447
+8% +$239K ﹤0.01% 1855
2015
Q1 		$3.18M Buy
18,651
+117
+0.6% +$17.7K ﹤0.01% 1795
2014
Q4 		$2.83M Buy
18,534
+1,590
+9% +$198K ﹤0.01% 1813
2014
Q3 		$1.8M Buy
16,944
+357
+2% +$49.7K ﹤0.01% 2017
2014
Q2 		$2.52M Sell
16,587
-52
-0.3% -$6.92K ﹤0.01% 1859
2014
Q1 		$2.14M Buy
16,639
+1,029
+7% +$160K ﹤0.01% 1921
2013
Q4 		$2.72M Buy
15,610
+44
+0.3% +$7.56K 0.01% 1712
2013
Q3 		$2.55M Buy
15,566
+1,815
+13% +$286K 0.01% 1698
2013
Q2 		$1.93M Buy
+13,751
New +$1.94M ﹤0.01% 1784

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Charles Schwab's ELGX Position: Q3 2019 in Review

Charles Schwab sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 71,343 shares — an estimated $517K sold.

Charles Schwab first reported a position in ELGX in Q2 2013 and held it in 25 quarters. The position peaked at $3.55M in Q3 2016. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • Charles Schwab reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • Charles Schwab sold 71,343 Endologix Inc shares in Q3 2019, an estimated $517K.
  • Charles Schwab first reported a position in Endologix Inc in Q2 2013 and held it in 25 quarters.
  • Charles Schwab's Endologix Inc position peaked at $3.55M in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on Charles Schwab's 13F filing for Q3 2019, filed 8 Nov 2019.